MetLife Inc Preferred Stock Series A (MET-PA)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from MET-PA's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from MetLife Inc Preferred Stock Series A's 10-K filings. The deep dive has 15+ years, quarters and every line.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $68.7B | $68.8B | $66.9B | $71.0B | $77.1B |
| Net income | $6.9B | $5.3B | $1.6B | $4.4B | $3.4B |
| Free cash flow | — | — | — | — | — |
| EPS (diluted) | $7.65 | $6.30 | $1.81 | $5.94 | $4.71 |
| Operating margin | — | 8.7% | 8.6% | 8.4% | 8.0% |
Where the revenue comes from
Revenue by segments, fiscal 2023.
Superinvestors who own MET-PA
From each investor's latest 13F filing (what a 13F shows).
Insider buying
Open-market purchases by MetLife Inc Preferred Stock Series A's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when MET-PA trades at or below it.
Free accounts get 3 price alerts. No card needed.
In the full deep dive
Questions
Are MetLife Inc Preferred Stock Series A insiders buying the stock?
No open-market insider purchases of MET-PA in the last 12 months, according to SEC Form 4 filings.
Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.